Phase 1/1b Trial Of Olutasidenib And Ziftomenib For NPM1 And IDH1 Co-Mutated Acute Myeloid Leukemia
Clinical trial NCT07411586 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07411586
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-28
- Primary completion
- 2027-01-14
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.